//fpnotebook.com/
Rho Kinase Inhibitor
Aka: Rho Kinase Inhibitor, Netarsudil, Rhopressa- Indications
- Mechanism
- New, expensive class of Open Angle Glaucoma medication released in 2018
- Increases ocular fluid overflow
- Preparations
- Netarsudil (Rhopressa)
- Adverse Effects
- Eye Redness (>50% of patients)
- References
- (2018) Presc Lett 25(5):28